Phlexglobal en Luz werken samen aan eTMF en vertaling medische dossiers
AMERSHAM & MALVERNP & SAN FRANCISCO–(BUSINESS WIRE)– Phlexglobal, pionier in Trial Master File (TMF) en servicesystemen, maakt samen met LUZ, wereldwijd toonaangevend in vertalingen voor de levenswetenschappen, bekend dat ze een samenwerking aangaan. De twee bedrijven bieden een compleet vertaal- en eTMF-systeem.
“We zijn erg blij dat we een samenwerking zijn aangegaan met een toonaangevende TMF-systeemleverancier als Phlexglobal”, zei Monique Rivas, medeoprichter en ceo van LUZ. “Deze strategische alliantie stelt beide bedrijven in staat hun kerncompetenties in te zetten door middel van twee elkaar versterkende systeemportfolio’s. Nog belangrijker is het feit dat bedrijven uit de levenswetenschappen die grotere integratie van TMF-diensten en medische vertaaldiensten nastreven, deze samenwerking zullen zien als een logische stap voor transparantere en effectievere hulp bij medische onderzoeken.”
Phlexglobal and LUZ Form Partnership to Provide eTMF and Clinical Document Translation Services
AMERSHAM, UK & MALVERN, Pa. & SAN FRANCISCO–(BUSINESS WIRE)– Phlexglobal, pioneers in the provision of Trial Master File (TMF) technology and services solutions, and LUZ, the world’s leading language translation company for life sciences, today announced they have entered into a partnership to offer a full eTMF and document translation solution.
This Smart News Release features multimedia. View the full release here:http://www.businesswire.com/news/home/20160504006011/en/
By introducing a working relationship and marketing alliance, the two organizations will be able to co-present business opportunities and co-market their capabilities.
“We are very pleased to have partnered with a leading TMF solution provider such as Phlexglobal,” comments Monique Rivas, co-founder and CEO LUZ. “This strategic alliance enables both companies to deploy their core competencies in a seamless fashion through a complimentary solution portfolio. More importantly, life science companies that seek greater integration of TMF services and technologies and clinical document translation services and technologies will find this partnership a logical step for enabling more transparent and effective support during clinical trials.”
“Life sciences companies require translations of key essential clinical documents that become part of their TMF. These translations must meet quality standards and be completed in a timely manner,” comments Rick Riegel, CEO Phlexglobal. ”Our partnership with LUZ allows us to incorporate translations into our business process to ensure inclusion in the TMF and brings a clinical translation solution to our clients.”
About Phlexglobal
Phlexglobal is a specialist provider of both industry leading eTMF technology solutions and expert TMF & eTMF technology-enabled services. Offering a unique combination of clinical trial knowledge, document management skills, regulatory understanding and technical expertise, we deliver a range of flexible, targeted solutions to meet business needs.
More information can be found at http://www.phlexglobal.com
About LUZ
Founded in 1994, LUZ is the world’s leading language translation company for life sciences. With a special focus on medical device, pharmaceutical, biotechnology, and clinical research organizations, we simplify and speed up entry into global markets by delivering accurate and compliant translations of product and regulatory documentation. Our cloud-based AURORA translation management platform minimizes risk for the world’s top life science companies through real-time project management, predictive analytics, and centralized translation memory management.
More information can be found at: http://www.luz.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20160504006011/en/
Contacts
Phlexglobal
Gillian Gittens, +44-1494-720420
Head of Marketing
ggittens@phlexglobal.com
o r
LUZ
Waldemar Frank, +1-415-981-5890 ext. 138
Vice President, Product Management & Marketing
waldemar.frank@luz.com